Salud financiera de hoja de balance de SMS Pharmaceuticals
Salud financiera controles de criterios 4/6
SMS Pharmaceuticals tiene un patrimonio de accionistas total de ₹5.6B y una deuda total de ₹2.9B, lo que sitúa su ratio deuda-patrimonio en 50.6%. Sus activos y pasivos totales son ₹11.3B y ₹5.7B respectivamente. El BAIT de SMS Pharmaceuticals es de ₹955.7M, por lo que su ratio de cobertura de intereses es de 5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹90.7M.
Información clave
50.6%
Ratio deuda-patrimonio
₹2.85b
Deuda
| Ratio de cobertura de intereses | 5x |
| Efectivo | ₹90.66m |
| Patrimonio | ₹5.64b |
| Total pasivo | ₹5.71b |
| Activos totales | ₹11.35b |
Actualizaciones recientes sobre salud financiera
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22Recent updates
Risks Still Elevated At These Prices As SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares Dive 25%
Nov 14SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹5.8B) de SMSPHARMA superan a sus pasivos a corto plazo (₹3.8B).
Pasivo a largo plazo: Los activos a corto plazo de SMSPHARMA (₹5.8B) superan a sus pasivos a largo plazo (₹2.0B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de SMSPHARMA (49%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de SMSPHARMA ha crecido de 43.2% a 50.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de SMSPHARMA está bien cubierta por el flujo de caja operativo (22.9%).
Cobertura de intereses: Los pagos de intereses de la deuda de SMSPHARMA están bien cubiertos por el BAIT (5x cobertura).